Hillsdale Investment Management’s Guardant Health GH Stock Holding History

Hillsdale Investment Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.5M	Buy	124,384 +2,004	+2%	+$201K	0.31%	49
2025 Q4	$12.5M	Sell	122,380 -33,520	-22%	-$3M	0.35%	50
2025 Q3	$9.74M	Buy	155,900 +19,800	+15%	+$1.08M	0.29%	55
2025 Q2	$7.08M	Buy	+136,100	New	+$6.08M	0.26%	67
2024 Q1	–	Sell	-136,380	Closed	-$3.69M	–	626
2023 Q4	$3.69M	Sell	136,380 -9,720	-7%	-$255K	0.3%	132
2023 Q3	$4.33M	Buy	+146,100	New	+$5.14M	0.4%	75

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hillsdale Investment Management's GH Position: Q1 2026 in Review

Hillsdale Investment Management increased its Guardant Health (GH) stake by 1.6% in Q1 2026, buying an estimated $201K and bringing the position to 124,384 shares worth $11.5M. The position accounts for 0.31% of the portfolio, ranked #49.

Hillsdale Investment Management first reported a position in GH in Q3 2023 and has held it in 6 quarters since. The position peaked at $12.5M in Q4 2025. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Hillsdale Investment Management held 124,384 shares of Guardant Health worth $11.5M as of Q1 2026.
Hillsdale Investment Management bought 2,004 Guardant Health shares in Q1 2026, an estimated $201K.
Guardant Health made up 0.31% of Hillsdale Investment Management's portfolio in Q1 2026, its #49 holding.
Hillsdale Investment Management first reported a position in Guardant Health in Q3 2023 and has held it in 6 quarters since.
Hillsdale Investment Management's Guardant Health position peaked at $12.5M in Q4 2025.
482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.